Scandinavian biopharma

27 September 2018 13:25

We are proud to be "2018 Distributor of the year"

Standing out from keen competitions, we are very proud to announce that we were the winner of the “2018 Distributor of the Year” award at AJ Vaccines Summit last week.

Professor Ann-Mari Svennerholm från Göteborgs universitet, Björn Sjöstrand, VD på Scandinavian Biopharma och Ambassadör Annika Thunborg

5 Juli 2018 10:51

Sveriges ambassadör Annika Thunborg deltog på VASE konferensen i Mexiko City

Ambassadören presenterade under mötet Sveriges aktiva roll inom Global Hälsa, vilken avgörande roll nya vacciner inom diarréområdet kan spela generellt och hur vacciner även kan minska det överhängande globala hotet från antibiotikaresistens.

Sweden's ambassador in Mexico Annika Thunborg and Dr. Richard Walker, Director of the Enteric Vaccine Initiative at PATH and in charge of the VASE Conference 2018, after her closing remarks during VASE 2018.

5 Juli 2018 10:45

Sweden's ambassador Annika Thunborg attended the VASE conference in Mexico City

During VASE 2018 the Ambassador presented Sweden's strategy in Global Health, the essential and lifesaving role new vaccines play in the field of diarrhoeal disease and how vaccines can reduce the imminent global threat of antibiotic resistance.

Den 12–14 juni arrangeras konferensen 2nd International Vaccines Against Shigella and ETEC (VASE) i Mexiko City.

11 Juni 2018 10:54

Nya kliniska ETVAX®-data presenteras vid VASE-konferens i Mexiko

Den 12–14 juni arrangeras International Vaccines Against Shigella and ETEC (VASE) i Mexiko City. Under mötet samlas världsledande forskare tillsammans med centrala beslutsfattare från WHO, Bill & Melinda Gates Foundation, PATH och ledande forskningsinstitut för att diskutera vacciner mot diarrésjukdomar orsakade av Shigella och ETEC. Vårt ETEC-vaccin, ETVAX®, är naturligtvis på agendan.

The 2nd International Vaccines Against Shigella and ETEC(VASE) Conference will be held on June 12 to 14, in Mexico City, Mexico.

11 Juni 2018 10:51

New ETVAX® data will be presented during Vaccines Against Shigella and ETEC (VASE) conference in Mexico

The International Vaccines Against Shigella and ETEC(VASE) Conference will be held on June 12 to 14, in Mexico City, Mexico. The aim of this collaborative, interactive gathering is to accelerate the development and introduction of vaccine to prevent and control diarrheal diseases. Our ETEC-vaccine, ETVAX®, is of course on the agenda when the global development of ETEC vaccines will be discussed

Kyoko Misawa, Clinical study manager at Scandinavian Biopharma

1 Juni 2018 11:07

Kyoko Misawa joins Scandinavian Biopharma as Clinical study manager

Scandinavian Biopharma continues to expand and strengthen its organization. In April Kyoko Misawa started as Clinical Study Manager at Scandinavian Biopharma’s research subsidiary ETVAX AB. Kyoko has more than 20 years’ experience from the pharmaceutical and life science industry in both Japan and Sweden within the field of diabetes, antibiotic, inflammation and orphan drugs

Kyoko Misawa, Clinical Study Manager på Scandinavian Biopharma

1 Juni 2018 10:47

Kyoko Misawa till Scandinavian Biopharma som Clinical study manager

Scandinavian Biopharma fortsätter att expandera och förstärka sin organisation. I april började Kyoko Misawa som Clinical Study Manager på Scandinavian Biopharma’s forskningsbolag ETVAX AB. Kyoko har mer än 20 års erfarenhet från läkemedels- och Life Science industrin från både Japan och Sverige inom områderna diabetes, antibiotika, inflammation och orphan drugs.

22 Maj 2018 16:14

Scandinavian Biopharma is once again looking back on a highly successful business year

We are very proud to report completion of a large Phase I/II child study in Bangladesh, we were awarded 30 MSEK from Horizon 2020 SME and we kick-started a Phase IIB study on travellers to Benin. We have strengthened our organization and continued to grow our distribution business.

Tillväxt Scandinavian Biopharma 2009-2017

22 Maj 2018 16:07

Framgångssagan fortsätter för Scandinavian Biopharma

Vi kan se tillbaka på ett fantastiskt år där några av höjdpunkterna var att vi slutförde en fas I/II-barnstudie i Bangladesh på 450 personer, vi beviljades 30 miljoner kronor av Horizon 2020 och på rekordtid startades en fas IIB studie på resenärer till Benin. Vi har dessutom flyttat till nya lokaler, förstärkt vår organisation och fortsatt utveckla vår distributionsverksamhet.

27 April 2018 16:43

Meet Scandinavian Biopharma at Northern European Conference on Travel Medicine (NECTM 7) in Stockholm

From May 2nd to May 4th, over 500 delegates will gather in Stockholm for the main Travel medicine conference in 2018. The conference has a comprehensive scientific program and delegates mainly from northern Europe meet here to discuss common travel health topics and advances in travel medicine. Key achievements for our ETEC vaccine candidate will be presented during the scientific sessions.

25 April 2018 15:05

Scandinavian Biopharma gets support by the County Administrative Board in Stockholm

Scandinavian Biopharma Distribution (SBD) has been granted a business development check by the County Administrative Board in Stockholm. Business Development checks are the County Administrative Board's support for companies that want to take in external skills to develop the company and strengthen its competitiveness. The support for SBD will be used for internationalization of the business.

25 April 2018 15:00

Scandinavian Biopharma Distribution får stöd av Länsstyrelsen i Stockholm

Scandinavian Biopharma Distribution (SBD) har beviljats en affärutvecklingscheck på 250 000 SEK av Länsstyrelsen i Stockholm. Affärsutvecklingscheckar är Länsstyrelsens stöd till företag som vill ta in extern kompetens för att utveckla företag och stärka dess konkurrenskraft. Stödet till SBD skall användas för internationalisering av verksamheten.

Nyhetsarkiv